Sera Prognostics Inc Class A SERA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Trading Information
- Previous Close Price
- $2.08
- Day Range
- $2.08–2.08
- 52-Week Range
- $1.56–3.85
- Bid/Ask
- $2.01 / $2.10
- Shares Outstanding
- 39.77M
- Market Cap
- $82.72M
- Volume/Avg
- 1,103 / 22,628
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,091.86
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 72
Valuation
Metric | SERA |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.58 |
Price/Sales | 1,091.86 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | SERA |
|---|---|
Quick Ratio | 1.80 |
Current Ratio | 1.88 |
Interest Coverage | −6,174.83 |
Quick Ratio
SERA
Profitability
Metric | SERA |
|---|---|
Return on Assets (Normalized) | −30.66% |
Return on Equity (Normalized) | −42.79% |
Return on Invested Capital (Normalized) | −46.24% |
Return on Assets
SERA
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|j#W#>x | LOCK|Y<>#x | $197B | |||
| Medtronic PLC MDT | LOCK|wM&$<g# | LOCK|nNSj$ | $134B | |||
| Stryker Corp SYK | LOCK|mSQ>N##D | LOCK|!@t | $128B | |||
| Boston Scientific Corp BSX | LOCK|Yl?>cD< | LOCK|?Xv^ | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|&!?H#?RZ | LOCK|xyG# | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|>hZM>F@ | LOCK|@w | $38B | |||
| DexCom Inc DXCM | LOCK|%yhpZWBd | LOCK|#R^xt | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|G% | LOCK|Gw | $30B | |||
| Steris PLC STE | LOCK|YGDMx@! | LOCK|MvL>J | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|srPC%l@ | LOCK|W!? | $20B |
United States